Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2023 Nov 14;13:18842. doi: 10.1038/s41598-023-44847-4

Asbestos-related cancer in naval personnel: findings from participants in the British nuclear tests 1952–1967

Richard T Gun 1,, Gerry M Kendall 2
PMCID: PMC10646006  PMID: 37963950

Abstract

Asbestos-containing materials (ACM) were present in British and Australian naval vessels throughout the twentieth century. The aim of this study was to identify and quantify the incidence of cancer in naval personnel from onboard asbestos exposure. Subjects were four cohorts of subjects who had served in the armed forces of the United Kingdom and Australia in the 1950s and 1960s. All cohorts had previously been studied, three of them in relation to radiation exposures from British nuclear testing. Comparisons of SIRs between services were made to identify cancers attributable to asbestos exposure. Excess mesotheliomas were found in naval personnel in all cohorts. In all but one cohort the lung cancer incidence was highest in navy personnel. Comparison of other smoking-related conditions indicated that the excess in navy personnel was not smoking-related. The relatively high SIRs for mesothelioma and the occurrence of deaths from asbestosis were indicative of high levels of asbestos exposure, with an expectation of cases of asbestos-related lung cancer. The findings are consistent with the occurrence of significant excesses of mesotheliomas. In addition, notwithstanding some inconsistencies in the results between the cohorts, we estimated that approximately 27% of lung cancers in Australian seamen and 12% in British seamen were related to onboard asbestos exposure.

Subject terms: Cancer, Risk factors

Introduction

Asbestos-containing materials (ACM) were present in British and Australian naval vessels throughout the twentieth century, and programs for asbestos elimination only began in the 1980s. Although the presence of ACM was widespread in naval vessels, the greatest likelihood of onboard exposure to airborne asbestos was to personnel working in engine rooms, where maintenance procedures involved disturbance of asbestos on pipework, turbines, boilers and other machinery. While general exhaust ventilation was provided in engine rooms (mainly for thermal comfort), safety measures which are now mandatory (e.g. local exhaust ventilation, masking of work areas, double locker rooms, supplied air respirators) did not apply at the time.

Several epidemiological studies of both naval and merchant mariners (summarised in Supplementary Table S1), have demonstrated excess mesotheliomas resulting from onboard asbestos exposure. There is less certainty as to the occurrence of asbestos-related lung cancers (ARLC). Excess lung cancer incidence or mortality has been found in nearly all studies, and while smoking data were mostly lacking, the incidence or mortality of other smoking-related cancers can indicate whether there is any unaccountable excess which could be attributed to occupational factors such as asbestos. Taking these factors into account, some studies have been suggestive of excess lung cancers from asbestos but most were inconclusive19. In the present context, a large mortality study of US nuclear test participants reported effects of asbestos exposure on mesothelioma and asbestosis in naval personnel, though a clear link with lung cancer was not established9.

While it is not possible to distinguish lung cancer cases caused by asbestos from those that are not, the likelihood of any ARLC cases may be estimated from cumulative exposure: coefficients of dose–response relationships have been generated for each of the asbestos fibre types and for mixed fibres10. High concentrations of airborne asbestos concentrations have been reported in British naval dockyards11,12, but no records of onboard asbestos exposure in British or Australian naval vessels have been located. Epidemiological studies have used proxies for exposure such as location (e.g. engine room) or duration of employment rather than actual asbestos exposure. In a review of asbestos-related cancer in naval personnel, Lemen and Landrigan cite asbestos exposures in US naval vessels orders of magnitude above permissible exposure limits during certain maintenance procedures, but no time-weighted average (TWA) exposure estimates were given13.

In the absence of exposure measurements, the likelihood and rate of occurrence of ARLCs in naval personnel may be inferred by comparing their mesothelioma incidence with those of other occupations. Gilham et al. have shown risks for both mesothelioma and ARLC incidence to be proportional to the asbestos fibre concentration in the lungs, and implicitly to cumulative exposure14. Therefore the highest proportion of lung cancers caused by asbestos are likely to be found in occupations with the highest mesothelioma incidence.

Another indicator of the likelihood of ARLC is the occurrence of asbestosis. There is evidence of a threshold exposure level of asbestos of 2 fibre/ml years, below which asbestosis does not occur15. Furthermore, a necropsy study of amphibole asbestos miners has shown asbestosis to be a significant risk factor for bronchial cancer, independent of cumulative fibre exposure16.

The aim of this study is to identify and, so far as is possible, to quantify any contribution from onboard asbestos exposure to the mesothelioma and lung cancer burden in British and Australian naval personnel.

Material and methods

Most of the data presented herewith are derived from previously-published studies, as referenced.

The study population is comprised of four cohorts of Australian and British service personnel. Two cohorts are derived from British and Australian participants in the British atmospheric nuclear tests undertaken primarily in the 1950s (minor trials and clean-up operations continued into the 1960s). In the study of 21,357 British participants, cancer and mortality rates were compared with a control cohort of civilians and service personnel who had served overseas but not participated in the nuclear testing1720. The control cohort contained a similar mix of subjects from the different armed services, and of officers and other ranks, as the cohort of test participants, and were also similar in matters such as date of birth21. The small percentage of civilians in each cohort were excluded from the present study.

A separate study of 8728 Australian test participants was completed in 20082225. Of this cohort 30% were civilians and were not included in the present study. There was no matched cohort of control subjects in the Australian study, but a contemporary cohort was available for comparison: Australian veterans of the Korean War26,27 (it was however not a fully independent cohort as 15% of the test participants had also served in Korea.)

The studies (other than of the Korean War veterans) were originally designed with a main objective of identifying any association between cancer incidence and radiation exposure, and we have summarised the effects of radiation in recent publications28,29. There was no indication of a link between lung cancer and radiation dose in the Australian22,25, British17, or US9 Studies.

In both the British and Australian studies the SIRs and SMRs were computed by comparison with the respective national male population, indirectly standardised by age and year of occurrence, using standard software programs. In computing confidence intervals both studies, observed cases were assumed to have a Poisson distribution.

For the present study, mortality and cancer data in naval veterans were compared with those of the army and the air force. To assess the contribution of smoking to lung cancer incidence, comparison of other smoking-related conditions was made by service. The analyses were based on tables from the published reports of the Australian and British nuclear test participants and of Australian Korean War veterans. Additional analyses (Table S2) were provided by the authors of the most recent update of the British study17. For the convenience of readers, approximate summaries of these data are also provided in which expected numbers were estimated by dividing observed numbers by the respective SIRs or SMRs.

Since the likelihood and incidence rate of ARLC is related to cumulative asbestos exposure and therefore to mesothelioma incidence, we compared SIRs of mesothelioma in naval veterans with high-risk occupations from two published studies: a study of mesothelioma mortality in Great Britain, in which risk was measured as proportional mortality ratio (PMR)30, and a study of mesothelioma incidence in Connecticut, in which the effect measure was Relative Risk, computed from Mantel–Haenszel odds ratios31.

Data on deaths from asbestosis by service were supplied by the authors of the update of the UK cohort study. Asbestosis deaths in the Australian cohort could not be ascertained as the data set is no longer readily available.

To estimate the number of lung cancers attributable to asbestos in naval veterans, we multiplied the expected number by the SIR for army veterans as an approximation for the number expected from smoking, and subtracted the product from the observed number in naval veterans.

Ethics approval

The Human Research Ethics Committee of the University of Adelaide has authorised this project as exempt from requiring ethical review.

Results

The number of subjects in each cohort, by service, and the percentage of officers in each are shown in Table 1.

Table 1.

Number of subjects and percentage of officers in each cohort by service.

Navy Army Air force
n % officers n % officers n % officers
UK test participants 6305 7.7 5794 9.7 8443 19.1
UK control cohort 7343 7.9 5462 12.1 8702 20.7
Australian test participants 2613 9 1037 24 2459 22
Australian Korean War veterans 5102 NA 8934 NA NA NA

NA no data available.

Standardised Incidence Ratios (SIRs) for mesothelioma by service in the four cohorts are shown in Table 2. SIRs were elevated in naval veterans, and all elevations were statistically significant other than for the Australian Korean War veterans. Non-significant excesses were detected in British army veterans. SIRs were less than unity for Australian army veterans and all air force veterans.

Table 2.

Standardised incidence ratios (SIRs) and 95% confidence intervals for mesothelioma in Australian and British nuclear test participants and control cohorts.

Navy Army Air Force
Australian TP 2.79 (1.59–4.52) 0.98 (0.12–3.54) 0
Australian KWV 1.75 (0.83–2.67) 0.83 (0.34–1.32) 0
UK TP 2.62 (2.04–3.31) 1.18 (0.79–1.68) 0.49 (0.29–0.77)
UK controls 2.57 (2.04–3.20) 1.34 (0.93–1.86) 0.53 (0.32–0.82)

TP nuclear test participants, KWV Korean War veterans.

The SIRs for lung cancer are shown in Table 3. The SIR is higher in naval personnel than in the other armed services, with the exception of army veterans of the Korean War, in whom the SIR was the highest of all.

Table 3.

Standardised incidence ratios (SIRs) and 95% confidence intervals for lung cancer in Australian and British nuclear test participants (TP) and control cohorts.

Navy Army Air force
Australian TP 1.50 (1.26–1.77) 1.09 (0.78–1.49) 1.04 (0.84–1.28)
Australian KWV 1.25 (1.08–1.42) 1.59 (1.44–1.74) 0.82 (0.54–1.10)
UK TP 1.16 (1.05–1.27) 1.02 (0.91–1.14) 0.94 (0.86–1.03)
UK controls 1.15 (1.05–1.25) 1.01 (0.90–1.13) 0.82 (0.86–1.03)

To assess the possible contribution of smoking, estimates were made for other smoking-related conditions. The estimates from the British study as shown in Table 4 are for test participants and controls combined.

Table 4.

Comparison between SIR for lung cancer and SIR for laryngeal cancer and standardised mortality ratio (SMR) for chronic obstructive pulmonary disease (COPD) by service, for both British cohorts combined.

Navy Army Air Force
Obs SIR/SMR Obs SIR/SMR Obs SIR/SMR
Lung cancer (SIR) 926 1.15 633 1.01 925 0.88
COPD (SMR) 418 0.93 313 0.97 410 0.67
IHD (SMR) 1934 0.92 1345 0.91 2129 0.76
Laryngeal cancer (SIR) 95 1.64 44 0.91 70 0.93
Bladder cancer (SIR) 269 1.00 217 1.05 316 0.91

Death rates from ischaemic heart disease (IHD) and chronic obstructive pulmonary disease (COPD) and incidence rates of bladder cancer in the navy and army are similar, suggesting that the excess lung cancers in the Naval veterans are not smoking-related. The SIR for laryngeal cancer is anomalous, being highest in the navy, and is discussed below. The estimates for the air force are all less than in the other services, suggesting a lower smoking prevalence than in the other services.

Similar comparisons in the Australian cohorts are shown in Table 5. For the test participants the SIRs for laryngeal and bladder cancer are higher in the army than the navy, suggesting that the higher SIR for lung cancer in the navy is not smoking-related (comparisons between the services for COPD and IHD mortality were not undertaken in the Australian study and the data sets are no longer readily available). As in the UK cohorts, the SIRs/SMRs are consistently less in the air force for all smoking-related conditions, again with the exception of bladder cancer.

Table 5.

SIRs and SMRs of selected smoking-related conditions in Australian test participants and Korean War veterans.

Navy Army Air Force
Obs SIR/SMR Obs SIR/SMR Obs SIR/SMR
Nuclear test participants
 Lung cancer 138 1.50 39 1.09 94 1.04
 Laryngeal cancer 16 1.51 7 1.82 13 1.35
 Bladder cancer 30 1.07 13 1.14 37 1.29
Korean war veterans
 Lung cancer 203 1.25 435 1.59 32 0.82
 Laryngeal cancer 27 1.40 65 2.05 3 0.71
 Bladder cancer 63 1.31 85 1.03 14 1.16
 IHD (SMR) 582 1.04 1230 1.18 139 0.84
 COPD (SMR) 101 1.30 241 1.69 20 0.85

For the Korean veterans the mortality and incidence rates of smoking-related conditions are very high in army veterans. Even for lung cancer the SIR is higher in the army than in the navy. An exception is the lower SIR for bladder cancer in the army.

Comparison of mesothelioma risk with other occupations.

In Table 6, SIRs for mesotheliomas in naval personnel are compared with all occupations in two other studies in which the risk was more than doubled (i.e. PMR or RR > 2).

Table 6.

Mesothelioma SIRs in naval personnel compared with occupations with the highest ranked PMRs /RRs from other published studies.

Source Occupation Risk estimate 95% CI
Current study—naval personnel (SIR) Australian TP 2.79 1.59–4.52
Australian KWV 1.75 0.83–2.67
UK TP 2.62 2.04–3.31
UK controls 2.57 2.04–3.20
McElvenny et al. (PMR)30 Metal plate workers 5.02 4.44–5.65
Vehicle body builders 5.26 4.19–6.52
Plumbers and gas fitters 4.13 3.81–4.46
Carpenters 3.88 3.62–4.13
Electricians 2.79 2.55–3.04
Electrical plant operators 2.63 1.97–3.43
Electrical /electronic production fitters 2.60 1.71–3.78
Sheet metal workers 2.35 1.98–2.73
Chemical engineers and scientists 2.21 1.65–2.90
Boiler operators 2.19 1.75–2.72
Electrical engineers 2.16 1.81–2.53
Construction workers nec 2.13 1.95–2.32
Production fitters 2.09 1.96–2.24
Teta et al. (RR computed from Mantel–Haenszel odds ratio)31 Plumbers and pipefitters 3.87 1.38–10.82
Engineers 2.72 0.86–8.68
Cabinetmakers and carpenters 2.25 1.13–4.48
Brickmasons and stonemasons 2.15 0.37–12.50

The SIRs in the naval personnel are shown to be comparable to those of the occupations ranked with the highest risk in both studies. Only four occupational categories in the UK study and two in the Connecticut study had higher SIRs for mesotheliomas.

Asbestosis

In the UK cohort the number of deaths from asbestosis, for test participants and controls combined, was 12 in the navy (SMR 2.51), 2 in the army (SMR 0.51) and 4 in the air force (SMR (0.67).

Ratio of ARLCs to mesotheliomas

Using the methodology described in the Material and Methods section, we estimated that about 50 ARLCs occurred in British test participants, and 60 in controls. The mesothelioma numbers were respectively 70 and 81, giving a ratio of lung cancers to mesotheliomas of 0.74 for both cohorts.

A considerably higher ratio of 2.4 was estimated for Australian test participants.

Discussion

The high rates of mesothelioma seen only in naval veterans can be confidently attributed to onboard asbestos exposure, and are consistent with findings of other studies of naval and merchant seafarers, in particular in veterans of the US nuclear weapons testing9.

Lung cancer incidence was highest in the navy personnel and lowest in the air force, with the exception of the Korean War veterans’ cohort. The excess in naval personnel cannot be attributed automatically to asbestos: whereas most mesotheliomas are caused by asbestos, most lung cancers are not.

The largest excess of lung cancer in naval compared with army personnel is in Australian test participants, although the confidence intervals are wide: SIR 1.50 (1.26–1.77) in the navy vs 1.09 (0.78–1.49) in the army. While the difference in SIRs between the navy and the army is smaller in the British cohorts, the excess in the combined British cohorts is close to statistical significance: 1.15 (1.08–1.23) in the navy vs 1.01 (0.94–1.09) in the army (confidence intervals were estimated as (O/E)1±1.96/chi, where chi = (O − E)/√E).

It is likely that the low lung cancer incidence in the air force is at least partly due to a relatively high proportion of officers compared to other ranks. As shown in supplementary Table S2, officers have much lower lung cancer rates, whereas the proportion of officers in the navy and army cohorts are similar (Table 1). Comparisons between navy and army personnel are therefore not significantly confounded by rank (estimates of cancer SIR by rank were not undertaken in the Australian cohorts).

Comparisons of other smoking-related conditions showed that it is unlikely that the higher SIRs for lung cancer in naval personnel are due to higher smoking prevalence. Although in the British cohorts the SIRs for some conditions such as head and neck cancer and oesophageal and laryngeal cancer were higher in the navy, this may be alcohol-related: these cancers are related not only to smoking but to alcohol and an interactive combination of tobacco and alcohol3234. The SMR for liver cirrhosis in naval veterans of 2.19 and 2.45 for test participants and controls respectively, compared with 0.87 and 1.27 in army veterans, suggest higher alcohol use in the navy (Table 4 and Table S4 in the supplement). On the other hand, for conditions such as COPD, ischaemic heart disease and bladder cancer which are related to smoking but not alcohol use, the data for both British and Australian services suggest that, if anything, smoking prevalence was higher in the army than in the navy (there are however some inconsistencies, such as a higher SIR for bladder cancer in the navy in the Korean War veterans cohort).

Evidence of a higher smoking prevalence in the British army is supported by a 1991 study of smoking in men in the three main branches of the British armed forces. A questionnaire survey by Lodge found that those in the army smoked more than those in the RN or RAF (41%, 36% and 26% current cigarette smokers respectively35. The data relate to a period well after the nuclear weapons tests, but it is plausible that differences in smoking patterns between the three armed forces have been persistent. Higher levels of smoking in army recruits were also reported by Bray ten years later36.

In the exceptional case of Australian veterans of the Korean War, the lung cancer SIR was higher in the army than the navy. It is therefore not possible to identify any contribution from asbestos to the lung cancer incidence in the navy, although we may conjecture that any effect of asbestos is obscured by negative confounding from an exceptionally high smoking prevalence in the Australian army personnel who served in the Korean War.

Tables of tobacco- and alcohol-related conditions for all cohorts are summarised in Tables S3S5 in the supplement.

Since the lung cancer excesses in the navy are not explicable by higher smoking prevalence, asbestos is a likely alternative explanation. This is supported by the high SIRs for mesothelioma in naval veterans, comparable to those of occupations ranked with the highest levels of risk identified from other studies. High mesothelioma incidence indicates high cumulative asbestos exposure, with a corresponding high likelihood of some ARLCs.

This conclusion is supported by the occurrence of asbestosis deaths in the British navy, suggesting that the threshold exposure of 2fibre/ml years has been exceeded. The incremental risk of lung cancer for per fibre/ml year exposure to amphibole asbestos or mixed fibres has been estimated at 4.8%, so that the additional burden of lung cancer from asbestos exposure expected in an occupational group where asbestosis has occurred would be at least 10%10.

The low ratio of ARLCs to mesotheliomas in British naval personnel may reflect predominant exposure to crocidolite asbestos: in a review of 55 cohorts, McCormack and Peto found a mean of 0.7 ARLCs per mesothelioma for workers exposed to crocidolite, compared with ratios above unity for other fibres37. A report by Bartrip notes that by the end of World War 2, nearly all the major units of the British Fleet had their accommodation, engine rooms, and gun turrets insulated with sprayed limpet asbestos, a wet mixture of asbestos (usually crocidolite) water and cement12.

The higher ratio of 2.4 in Australian naval test participants suggests that the predominant exposure was to other species of asbestos.

These estimates equate to 27% of lung cancers in Australian seamen and 12% in British seamen being related to onboard asbestos exposure. The uncertainties in these estimates, which are substantial, include an assumption that absolute differences in observed cancers exactly equate to the number of ARLCs.

Strengths and weaknesses

Apart from lack of data on smoking or asbestos exposure, the principal drawback is the absence of mortality data on asbestosis and of smoking-related conditions (other than cancer) in the Australian cohort. Unlike the British cohort, this study has not been updated and the data set is no longer readily available.

While the number of subjects in these cohorts is less than in comparable studies (see Supplementary Table S1), they are sufficient to derive stable estimates, as shown by the relatively narrow confidence intervals, especially for lung cancer.

The inference of a significant number of ARLCs in naval veterans, derived from the comparison with other service veterans, is strengthened by the finding of cases of asbestosis, which is a risk factor for lung cancer independent of exposure levels.

Conclusion

Naval veterans have elevated rates of mesothelioma, not found in the other armed services, and attribution to onboard exposure to asbestos is non-contentious. They also have excess rates of lung cancer which are not fully explained by any differences in smoking prevalence.

The occurrence of mesothelioma is comparable to levels in occupational groups with the highest reported incidence or mortality from mesothelioma, suggesting that onboard exposures are comparable to those of industries with a high likelihood of ARLCs. Significant asbestos exposures are also indicated by the occurrence of asbestosis deaths in British naval veterans.

Notwithstanding some inconsistencies in the results between the cohorts, the findings are consistent with the occurrence not only of significant excesses of mesotheliomas but also of a substantial number of asbestos-related lung cancers.

Supplementary Information

Supplementary Tables. (34.3KB, docx)

Acknowledgements

We are grateful to Michael Gillies and Richard Haylock for providing unpublished results from their analyses of the British Nuclear Veterans cohorts (ref 16) and to the Naval Association of Australia, and numerous veterans of the Royal Australian Navy who provided advice and encouragement.

Abbreviations

ARLC

Asbestos-related lung cancer

SIR

Standardised incidence ratio

SMR

Standardised mortality ratio

IHD

Ischaemic heart disease

COPD

Chronic obstructive pulmonary disease

Author contributions

Both authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by R.G. The first draft of the manuscript was written by R.G. and both authors commented on successive versions of the manuscript. Both authors read and approved the final manuscript.

Data availability

The data presented in this paper are derived from previously-published studies. They can be accessed at the following websites: https://www.aihw.gov.au/getmedia/2cb2d58a-1d45-491a-ba2e-cb86b6a7e514/cis03.pdf.aspx?inline=true; https://www.dva.gov.au/sites/default/files/dosimetry_complete_study_1.pdf; https://www.dva.gov.au/sites/default/files/mortality_and_cancer_incidence_complete_study_1.pdf; https://www.aihw.gov.au/getmedia/3a5d6e95-2cf8-4dca-a384-b95b816bd263/Korean-Veterans-Mortality-Study.pdf.aspx?inline=true; https://iopscience.iop.org/article/10.1088/1361-6498/ac52b4.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-023-44847-4.

References

  • 1.Rafnsson V, Sulem P. Cancer incidence among marine engineers, a population-based study (Iceland) Cancer Causes Control. 2003;14(1):29–35. doi: 10.1023/a:1022505308892. [DOI] [PubMed] [Google Scholar]
  • 2.Pukkala E, Saarni H. Cancer incidence among Finnish seafarers, 1967–92. Cancer Causes Control. 1996;7(2):231–239. doi: 10.1007/BF00051299. [DOI] [PubMed] [Google Scholar]
  • 3.Saarni H, Pentti J, Pukkala E. Cancer at sea: A case-control study among male Finnish seafarers. Occup. Environ. Med. 2002;59(9):613–619. doi: 10.1136/oem.59.9.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Strand LA, Martinsen JI, Koefoed VF, Sommerfelt-Pettersen J, Grimsrud TK. Asbestos-related cancers among 28,300 military servicemen in the Royal Norwegian Navy. Am. J. Ind Med. 2010;53(1):64–71. doi: 10.1002/ajim.20778. [DOI] [PubMed] [Google Scholar]
  • 5.Brandt LP, Kirk NU, Jensen OC, Hansen HL. Mortality among Danish merchant seamen from 1970 to 1985. Am. J. Ind Med. 1994;25(6):867–876. doi: 10.1002/ajim.4700250610. [DOI] [PubMed] [Google Scholar]
  • 6.Rapiti E, Turi E, Forastiere F, Borgia P, Comba P, Perucci CA, Axelson O. A mortality cohort study of seamen in Italy. Am. J. Ind. Med. 1992;21(6):863–872. doi: 10.1002/ajim.4700210609. [DOI] [PubMed] [Google Scholar]
  • 7.Ugelvig Petersen K, Volk J, Kaerlev L, et al. Cancer incidence among merchant seafarers: An extended follow-up of a Danish cohort. Occup. Environ. Med. 2018;75:582–585. doi: 10.1136/oemed-2018-105037. [DOI] [PubMed] [Google Scholar]
  • 8.Ugelvig Petersen K, Pukkala E, Martinsen JI, Lynge E, Tryggvadottir L, Weiderpass E, Kjærheim K, Heikkinen S, Hansen J. Cancer incidence among seafarers and fishermen in the Nordic countries. Scand. J. Work Environ. Health. 2020;46(5):461–468. doi: 10.5271/sjweh.3879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Boice JD, Cohen SS, Mumma MT, Chen H, Golden AP, Beck HL, Till JE. Mortality among US military participants at eight aboveground nuclear weapons test series. Int. J. Radiat. Biol. 2022;98(4):679–700. doi: 10.1080/09553002.2020.1787543. [DOI] [PubMed] [Google Scholar]
  • 10.Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann. Occup. Hyg. 2000;44:565–601. doi: 10.1016/S0003-4878(00)00045-4. [DOI] [PubMed] [Google Scholar]
  • 11.Harries PG. Asbestos dust concentrations in ship repairing: A practical approach to improving asbestos hygiene in naval dockyards. Ann. Occup. Hyg. 1971;14(3):241–254. doi: 10.1093/annhyg/14.3.241. [DOI] [PubMed] [Google Scholar]
  • 12.Bartrip PWJ. ‘Enveloped in Fog’: The asbestos problem in Britain’s Royal Naval Dockyards 1949–1999. Int. J. Mar. History. 2014;26(4):685–701. doi: 10.1177/0843871414553740. [DOI] [Google Scholar]
  • 13.Lemen RA, Landrigan PJ. Sailors and the risk of asbestos-related cancer. Int. J. Environ. Res. Public Health. 2021;18(16):8417. doi: 10.3390/ijerph18168417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gilham C, Rake C, Burdett G, Nicholson AG, Davison L, Franchini A, Carpenter J, Hodgson J, Darnton A, Peto J. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occup. Environ. Med. 2016;73(5):290–299. doi: 10.1136/oemed-2015-103074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sluis-Cremer GK, Hnizdo E, du Toit RS. Evidence for an amphibole asbestos threshold exposure for asbestosis assessed by autopsy in South African asbestos miners. Ann. Occup. Hyg. 1990;34(5):443–451. doi: 10.1093/annhyg/34.5.443. [DOI] [PubMed] [Google Scholar]
  • 16.Hughes JM, Weill H. Asbestosis as a precursor of asbestos related lung cancer: Results of a prospective mortality study. Br. J. Ind Med. 1991;48(4):229–233. doi: 10.1136/oem.48.4.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gillies M, Haylock RGE. Mortality and cancer incidence 1952–2017 in United Kingdom participants in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes. J. Radiol. Prot. 2022;42(2):1. doi: 10.1088/1361-6498/ac52b4. [DOI] [PubMed] [Google Scholar]
  • 18.Darby SC, Kendall GM, Fell TP, O'Hagan JA, Muirhead CR, Ennis JR, Ball AM, Dennis JA, Doll R. A summary of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes. Br. Med. J. (Clin Res Ed). 1988;296(6618):332–338. doi: 10.1136/bmj.296.6618.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Darby SC, Kendall GM, Fell TP, Doll R, Goodill AA, Conquest AJ, Jackson DA, Haylock RG. Further follow up of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes. BMJ. 1993;307(6918):1530–1535. doi: 10.1136/bmj.307.6918.1530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Muirhead CR, Bingham D, Haylock RG, O'Hagan JA, Goodill AA, Berridge GL, English MA, Hunter N, Kendall GM. Follow up of mortality and incidence of cancer 1952–1998 in men from the UK who participated in the UK's atmospheric nuclear weapon tests and experimental programmes. Occup. Environ. Med. 2003;60(3):165–172. doi: 10.1136/oem.60.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kendall GM, Muirhead CR, Darby SC, Doll R, Arnold L, O'Hagan JA. Epidemiological studies of UK test veterans: I General description. J. Radiol. Prot. 2004;24(3):199–217. doi: 10.1088/0952-4746/24/3/001. [DOI] [PubMed] [Google Scholar]
  • 22.Gun RT, Parsons J, Crouch P, Ryan P, Hiller JE. Mortality and cancer incidence of Australian participants in the British nuclear tests in Australia. Occup. Environ. Med. 2008;65(12):843–848. doi: 10.1136/oem.2007.034652. [DOI] [PubMed] [Google Scholar]
  • 23.Crouch P, Robotham FR, Williams G, Wise K. Assessment of radiation doses to Australian participants in British nuclear tests. Radiat. Prot. Dosimetry. 2009;136(3):158–167. doi: 10.1093/rpd/ncp164. [DOI] [PubMed] [Google Scholar]
  • 24.Carter, M., Robotham, F., Wise, K., Williams, G., & Crouch, P. Australian participants in British nuclear tests in Australia, Vol 1: Dosimetry (Canberra: Department of Veterans Affairs, 2006).
  • 25.Gun, R. T., Parsons, J., Ryan, P., Crouch, P., & Hiller, J. E. Australian participants in British nuclear tests in Australia. Vol 2: Mortality and Cancer Incidence (Canberra: Department of Veterans Affairs, 2006). [DOI] [PubMed]
  • 26.Australian Institute of Health and Welfare (AIHW) 2003. Cancer incidence study 2003: Australian veterans of the Korean War. AIHW Cat. No. PHE 48 Canberra: AIHW.
  • 27.Harrex, W. K., Horsley, K. W., Jelfs, P., van der Hoek, R., Wilson, E. J. Mortality of Korean War veterans: The veteran cohort study. A report of the 2002 retrospective cohort study of Australian veterans of the Korean War (Department of Veterans’ Affairs, Canberra, 2003).
  • 28.Kendall GM, Little MP. The new study of UK nuclear test veterans. J. Radiol. Prot. 2022;42(2):1. doi: 10.1088/1361-6498/ac6a23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gun R, Crouch P. Cancer in nuclear test veterans. J. Radiol. Prot. 2022;42(4):1. doi: 10.1088/1361-6498/ac9b63. [DOI] [PubMed] [Google Scholar]
  • 30.McElvenny DM, Darnton AJ, Price MJ, Hodgson JT. Mesothelioma mortality in Great Britain from 1968 to 2001. Occup. Med. (Lond). 2005;55(2):79–87. doi: 10.1093/occmed/kqi034. [DOI] [PubMed] [Google Scholar]
  • 31.Teta MJ, Lewinsohn HC, Meigs JW, Vidone RA, Mowad LZ, Flannery JT. Mesothelioma in Connecticut 1955–1977. J. Occup. Med. 1983;25(10):749–756. doi: 10.1097/00043764-198310000-00015. [DOI] [PubMed] [Google Scholar]
  • 32.Olshan, A. F., Hashibe, M. 'Cancer of the larynx. In Thun, M., et al. (eds), Cancer Epidemiology and Prevention, 4th edn (New York, 2017; online edn, Oxford Academic, 21 Dec. 2017). 10.1093/oso/9780190238667.003.0027, accessed 2 Mar 2023.
  • 33.Hashibe, M., et al. Oral cavity, oropharynx, lip, and salivary glands. In Thun, M., et al. (eds), Cancer Epidemiology and Prevention, 4th edn (New York, 2017; online edn, Oxford Academic, 21 Dec. 2017). 10.1093/oso/9780190238667.003.0029, accessed 2 Mar. 2023.
  • 34.Blot, W. J., & Tarone, R. E. Esophageal cancer. In Thun, M. (eds), Cancer Epidemiology and Prevention, 4th edn (New York, 2017; online edn, Oxford Academic, 21 Dec. 2017), 10.1093/oso/9780190238667.003.0030, accessed 2 Mar. 2023.
  • 35.Lodge LH. Tri-service health questionnaire-1989. J. R. Army Med. Corps. 1991;137(2):80–83. doi: 10.1136/jramc-137-02-05. [DOI] [PubMed] [Google Scholar]
  • 36.Bray I, Richardson P, Harrison K. Smoking prevalence amongst UK Armed Forces recruits: Changes in behaviour after 3 years follow-up and factors affecting smoking behaviour. J. R. Army Med. Corps. 2013;159(1):44–50. doi: 10.1136/jramc-2013-000009. [DOI] [PubMed] [Google Scholar]
  • 37.McCormack V, Peto J, Byrnes G, Straif K, Boffetta P. Estimating the asbestos-related lung cancer burden from mesothelioma mortality. Br. J. Cancer. 2012;106(3):575–584. doi: 10.1038/bjc.2011.563. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Tables. (34.3KB, docx)

Data Availability Statement

The data presented in this paper are derived from previously-published studies. They can be accessed at the following websites: https://www.aihw.gov.au/getmedia/2cb2d58a-1d45-491a-ba2e-cb86b6a7e514/cis03.pdf.aspx?inline=true; https://www.dva.gov.au/sites/default/files/dosimetry_complete_study_1.pdf; https://www.dva.gov.au/sites/default/files/mortality_and_cancer_incidence_complete_study_1.pdf; https://www.aihw.gov.au/getmedia/3a5d6e95-2cf8-4dca-a384-b95b816bd263/Korean-Veterans-Mortality-Study.pdf.aspx?inline=true; https://iopscience.iop.org/article/10.1088/1361-6498/ac52b4.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES